CEP
NXTM

Chicago Equity Partners’s NxStage Medical Inc. NXTM Stock Holding History

Chicago Equity Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-79,930
Closed -$2.15M – 893
2017
Q1 		$2.15M Buy
79,930
+390
+0.5% +$10.8K 0.06% 305
2016
Q4 		$2.08M Buy
+79,540
New +$1.97M 0.06% 325

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Chicago Equity Partners's NXTM Position: Q2 2017 in Review

Chicago Equity Partners sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 79,930 shares — an estimated $2.15M sold.

Chicago Equity Partners first reported a position in NXTM in Q4 2016 and held it in 2 quarters. The position peaked at $2.15M in Q1 2017. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

  • Chicago Equity Partners reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 79,930 NxStage Medical Inc. shares in Q2 2017, an estimated $2.15M.
  • Chicago Equity Partners first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 2 quarters.
  • Chicago Equity Partners's NxStage Medical Inc. position peaked at $2.15M in Q1 2017.
  • 163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Chicago Equity Partners's 13F filing for Q2 2017, filed 9 Aug 2017.